Novacyt S.A. (EPA:ALNOV)
France · Delayed Price · Currency is EUR 0.4900
+0.0150 (3.16%)
Jun 3, 2026, 5:35 PM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €34.42 million as of June 3, 2026. Its market cap has decreased by -8.62% in one year.
Market Cap
34.42M
Enterprise Value
24.31M
Revenue
22.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.49
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 34.42M, an increase of 46.12%. That is a compound annual growth rate of 2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 34.42M | 24.84% |
| Dec 31, 2025 | 27.57M | -35.08% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 219.49M |
| Median Technologies | 202.88M |
| Carvolix | 195.50M |
| Guerbet | 134.98M |
| Theraclion | 50.88M |
| Diagnostic Medical Systems | 32.50M |
| Implanet | 26.55M |
| Ikonisys | 25.35M |